ArticleHuman gene therapy2016

Using Patient-Specific Induced Pluripotent Stem Cells and Wild-Type Mice to Develop a Gene Augmentation-Based Strategy to Treat CLN3-Associated Retinal Degeneration.

Luke A Wiley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.